BIOWEG
PrivateLast Round
Grant
Jan 19, 2026
Est. Valuation
$95M
Total Funding Raised
$26.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BIOWEG is a biotechnology company that produces biodegradable, bio-based ingredients to replace microplastics and fossil-based polymers for the cosmetics, personal care, and agriculture industries.
Sector
Healthcare & Life Sciences
Verticals
Sustainable Materials, Biotechnology, Circular Economy, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOWEG Comparables
Compare BIOWEG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Naturbeads | 89% | |
| Cellugy | 86% | |
| Lignopure | 77% |
BIOWEG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 19, 2026 | ||||
| Series A | Sep 16, 2025 | ||||
| Accelerator | Feb 10, 2022 | ||||
| VC Round | Jan 6, 2022 | ||||
| Grant | Jan 6, 2022 | ||||
Seed | Dec 20, 2020 |
Key People
Founding team and executive leadership
BIOWEG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| RootCamp | Accelerator |
| NBank Capital | Series A |
| BonVenture | Series A |
| European Innovation Council Fund | Grant |
| SPRIND | Grant |
| EIC Fund | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 23% QoQ, from 30 to 37 employees.
- Jan 19, 2026
Secured $1.76M in grant funding.
Recent news
Latest coverage and updates
- expands_facilitiesSep 22, 2026
Bioweg will expand facilities to Europe on Oct 1st '26.
- receives_financingSep 22, 2026
Bioweg received financing of $2.3M in equity on Sep 22nd '26.
- receives_financingSep 14, 2026
Bioweg received financing of $34.8M in Series A on Sep 14th '26.
- receives_financingSep 14, 2026
Bioweg received financing of $11.9M in EU funding on Sep 14th '26.
- expands_facilitiesSep 12, 2026
Bioweg expanded facilities to Germany, Western Europe, Europe on Jul 1st '26.
BIOWEG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BIOWEG's valuation, stock price, and market status.
Is BIOWEG a public or private company?
BIOWEG is a private company.
What is the current stock price of BIOWEG?
BIOWEG is a private company with no public stock price. No recent secondary market data is available.
How much is BIOWEG worth (valuation)?
BIOWEG's valuation is estimated at $95.0M based on funding round data.
Can I buy BIOWEG stock?
BIOWEG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BIOWEG's last funding round?
BIOWEG's most recent funding round was Grant on September 16, 2025.
Who are the main investors in BIOWEG?
Key investors in BIOWEG include EIC Fund, Axeleo Capital.
Will BIOWEG IPO soon?
No public IPO plans have been announced for BIOWEG.
How can I track BIOWEG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BIOWEG's secondary market activity and sign up for updates.